Michel Lussier

Michel E.
Lussier is the founder of InControl, Inc., founded in 1990.
Mr. Lussier was the founder of MedPole SA, founded in 2002, and served as Chief Executive Officer from 2002 to 2020.
Mr. Lussier is the founder of Celyad Oncology SA, founded in 2007, and serves as Director since 2024.
Mr. Lussier is also the founder of Cardio3 SA..
Mr. Lussier is currently Chairman at iSTAR Medical SA since 2015, Chairman at Gabi SmartCare SA since 2021, Chairman at Occlutech AG, Chairman at Liva Healthcare A since 2023, Director at Biological Manufacturing Services SA since 2018, Director at Occlutech Holding AG since 2021, Director at Mel Management Co. since 2017, and Strategic Advisor at TO3 Capital Inc. Former positions include Chief Executive Officer & Director at Metronom Health, Inc. from 2015 to 2020, Chief Executive Officer at Medpole Ltd., Business Director at Cardiac Pacing Ltd., Managing Director at Volcano Europe BV, Director at Metronom Health Europe from 2017 to 2020, Vice President & General Manager-Europe at Novoste Corp.
from 1998 to 2002, and President-Clinical & Scientific Affairs at Philips Image Guided Therapy Corp.
from 2012 to 2013.
Education includes an MBA from INSEAD and undergraduate and graduate degrees from the University of Montréal.